Literature DB >> 14760408

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.

Haruhiko Akiyama, Patrick L McGeer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14760408     DOI： 10.1038/nm0204-117

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

Review 1.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

Review 2.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

Review 3.  Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation.

Authors:  Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.

Authors:  Erik S Musiek; Ginger L Milne; BethAnn McLaughlin; Jason D Morrow
Journal:  Brain Pathol       Date:  2005-04       Impact factor: 6.508

5.  Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.

Authors:  Dan Frenkel; Ruth Maron; David S Burt; Howard L Weiner
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

6.  Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

Authors:  Mitsuru Shinohara; Shinsuke Fujioka; Melissa E Murray; Aleksandra Wojtas; Matthew Baker; Anne Rovelet-Lecrux; Rosa Rademakers; Pritam Das; Joseph E Parisi; Neill R Graff-Radford; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Brain       Date:  2014-03-12       Impact factor: 13.501

7.  Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.

Authors:  Martina M Hughes; Robert H Field; V Hugh Perry; Carol L Murray; Colm Cunningham
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

8.  The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice.

Authors:  Mahito Yamada; Masafumi Ihara; Yoko Okamoto; Takakuni Maki; Kazuo Washida; Akihiro Kitamura; Yoshiki Hase; Hidefumi Ito; Keizo Takao; Tsuyoshi Miyakawa; Raj N Kalaria; Hidekazu Tomimoto; Ryosuke Takahashi
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

9.  Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.

Authors:  Leonel Rojo; Marcela K Sjöberg; Paula Hernández; Cristian Zambrano; Ricardo B Maccioni
Journal:  J Biomed Biotechnol       Date:  2006

10.  Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.

Authors:  Pritam Das; Lisa A Smithson; Robert W Price; Vallie M Holloway; Yona Levites; Paramita Chakrabarty; Todd E Golde
Journal:  J Neuroinflammation       Date:  2006-07-26       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.